What Is The Optimal Topical Anesthesia Preparation Protocol For Facial Resurfacing Performed With An Er:yag Laser? 5% Liposomal Lidocaine For 20 Minutes For Superficial Passes

For one- or two-pass facial Er:YAG resurfacing at 1–2 J/cm², the optimal topical protocol is generally 5% liposomal lidocaine applied for approximately 20 minutes before treatment. This regimen is described as providing adequate anesthesia for controlled ablative depths of about 20–40 µm, provided the treatment area, patient, product, and total dose are appropriate. It should not be generalized to deeper, extensive, or full-face ablative resurfacing, where additional analgesia or regional anesthesia may be required.

For shallow, limited Er:YAG resurfacing, 5% liposomal lidocaine used for 20 minutes can provide effective anesthesia without prolonged occlusion. The deeper or larger the treatment, the more important it becomes to use a documented, clinician-supervised multimodal anesthesia plan.

Match the Protocol to the Resurfacing Plan

Use 20 minutes for limited superficial treatment

For one or two Er:YAG passes at 1–2 J/cm², apply the 5% liposomal lidocaine preparation for approximately 20 minutes before laser exposure.

This protocol is intended for ablative depths of roughly 20–40 µm. The liposomal vehicle is used to support relatively rapid penetration and sustained release compared with conventional topical creams.

Treat the area and dose as safety variables

Topical anesthetic absorption depends on the concentration, application area, contact time, skin condition, and occlusion. The clinician should follow the specific product instructions and calculate the total amount applied, particularly when using compounded or high-concentration formulations.

Higher-concentration lidocaine/prilocaine preparations require conservative area limits. The supplementary guidance identifies approximately 300–400 cm² per session for formulations such as 15% lidocaine/5% prilocaine, but this is not a universal limit for every product or patient.

Adjust for deeper or more extensive ablation

Periorbital, perioral, or other small treatment zones may require a longer application, such as 90 minutes under occlusion, or topical anesthesia combined with local or regional injections.

For full-face ablative resurfacing, particularly when treatment is deeper or involves numerous passes, topical anesthesia alone is often inadequate. A clinician may need to add nerve blocks, infiltrative anesthesia, systemic analgesia, or another monitored anesthesia technique.

Prepare the Skin Correctly

Cleanse before applying anesthetic

The treatment area should be thoroughly cleansed with a mild cleanser. The anesthetic is then applied evenly to the planned treatment field according to the prescribed amount and contact time.

Occlusion should be used only when appropriate for the specific preparation and treatment plan. Longer occlusion times can increase anesthetic absorption and therefore require greater attention to dose and area.

Remove all anesthetic before firing

Before laser treatment, the topical anesthetic must be completely removed, using dry gauze as specified in the reference protocol. Residual cream can interfere with treatment conditions and may create avoidable safety concerns during laser exposure.

After removal, the clinician should confirm the treatment boundaries and assess the skin before beginning the procedure.

Protect the eyes and verify the equipment

Laser-specific protective eyewear is mandatory for the patient, operator, and assistant. If treating within the orbital rim, appropriate intraocular metal eye shields must be inserted by a trained clinician.

The handpiece should be disinfected, and laser calibration should be verified before treatment. These steps are part of the anesthesia and procedural safety protocol because patient movement, ocular injury, and equipment error can compromise both comfort and outcome.

Maintain Comfort During Treatment

Use the minimum effective treatment intensity

Er:YAG resurfacing produces less residual thermal injury than many other ablative laser approaches and removes a controlled, thin layer of tissue with each pass. For appropriate superficial treatments, this can make topical anesthesia alone sufficient.

The relevant question is not simply whether Er:YAG is being used, but whether the fluence, number of passes, ablation depth, treatment area, and patient sensitivity remain within the range supported by the topical protocol.

Reassess between passes

For multi-pass treatment, the clinician should reassess pain, erythema, tissue response, and patient tolerance between passes. Additional topical anesthetic may be applied to the treated skin only when clinically appropriate and within the product’s dosing and safety limits.

Pain that escalates unexpectedly should prompt reassessment of the treatment settings, anesthetic adequacy, and the need for a different analgesic strategy.

Avoid distorting treatment anatomy unnecessarily

Injected anesthetic can swell and flatten the skin, potentially obscuring scar contours, wrinkle bases, or other treatment boundaries. This is one reason topical anesthesia may be preferable when it provides sufficient analgesia and visual precision is important.

However, avoiding injection-related distortion does not justify inadequate pain control. If topical anesthesia is insufficient, patient comfort and procedural safety take priority.

Understanding the Trade-offs

Shorter application versus broader coverage

The principal advantage of 5% liposomal lidocaine in the specified Er:YAG setting is the relatively short 20-minute application period. Conventional creams may require longer contact times or occlusion, especially for localized procedures.

The trade-off is that this shorter protocol should not be assumed to provide adequate anesthesia for larger areas, deeper ablation, prolonged treatment, or multiple high-energy passes.

Topical anesthesia versus injected anesthesia

Topical anesthesia preserves the skin’s untreated topology and avoids needle discomfort, swelling, and possible distortion of treatment landmarks. It is most defensible when the expected pain burden is modest and the procedure is superficial and limited.

Injected, regional, or systemic anesthesia may be more appropriate when pain is expected to be substantial, but these methods add procedural, dosing, monitoring, and recovery considerations.

High-concentration preparations require caution

Compounded high-concentration topical anesthetics can produce excessive systemic absorption, particularly when applied over large areas, damaged skin, or under occlusion. Lidocaine toxicity is a serious potential complication.

The clinician must account for the product formulation, total dose, treatment surface, contact time, patient factors, and any additional local anesthetic administered during the session.

Making the Right Choice for Your Goal

The final regimen should be selected and supervised by the clinician performing the resurfacing, using the exact laser settings and anesthetic formulation.

If your primary focus is limited superficial resurfacing: Use 5% liposomal lidocaine for approximately 20 minutes for one or two passes at 1–2 J/cm², targeting about 20–40 µm of ablation when appropriate for the patient and product.
If your primary focus is localized periorbital or perioral treatment: Consider a longer occluded topical application, commonly around 90 minutes, or combine topical anesthesia with local or regional anesthesia when clinically indicated.
If your primary focus is full-face or deeper ablative resurfacing: Do not rely on the short topical-only protocol; develop a monitored multimodal plan that may include nerve blocks, infiltrative anesthesia, systemic analgesia, or another appropriate anesthesia technique.
If your primary focus is minimizing systemic risk: Use the lowest effective concentration and amount, restrict the treatment area when using high-concentration compounds, remove the anesthetic completely, and follow product-specific dosing and monitoring requirements.

The right protocol is defined by the relationship between anesthetic dose, treatment area, laser depth, number of passes, and patient tolerance, not by the laser name alone.

Summary Table:

Protocol	Application Time	Indication	Key Considerations
5% liposomal lidocaine	~20 minutes	1-2 passes at 1-2 J/cm², ablation depth ~20-40 µm	Limit to small areas; not for deep or full-face resurfacing
Higher concentration (e.g., 15% lidocaine/5% prilocaine)	90 minutes under occlusion	Periorbital/perioral, localized areas	Restrict area to 300-400 cm²; monitor for toxicity
Multimodal (topical + nerve blocks/analgesia)	Variable	Full-face or deep ablative resurfacing	Requires clinician-supervised anesthesia plan

Ensure safe and effective Er:YAG resurfacing with BELIS' advanced laser systems. Our Diode, Alexandrite, CO2 Fractional, Erbium, and Nd:YAG lasers are designed for clinics and premium salons. For expert guidance on anesthesia protocols and to explore our medical aesthetic equipment, contact us today and elevate your practice with BELIS.